Kaken Pharmaceutical Co., Ltd. (KKPCF)

Kaken Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	989	1,181	866	1,042	1,211	1,502
Market Cap Growth	36.32%	36.32%	-16.86%	-14.02%	-19.34%	-17.44%
Enterprise Value	532	674	454	544	697	916
Last Close Price	28.09	26.31	23.95	29.27	39.84	36.80
PE Ratio	10.62	12.68	16.32	25.45	15.41	12.39
PS Ratio	1.58	1.88	1.82	1.90	1.94	2.22
PB Ratio	0.97	1.16	0.91	1.01	1.06	1.22
P/TBV Ratio	1.11	1.33	0.96	1.07	1.14	1.23
P/FCF Ratio	5.78	6.90	182.95	19.06	14.21	13.39
P/OCF Ratio	4.97	5.94	50.83	14.96	11.03	11.55
EV/Sales Ratio	0.82	1.07	0.95	0.99	1.11	1.35
EV/EBITDA Ratio	3.27	4.28	5.60	6.85	4.33	5.04
EV/EBIT Ratio	3.66	4.80	7.22	9.04	4.96	5.69
EV/FCF Ratio	3.11	3.94	95.94	9.96	8.17	8.16
Debt / Equity Ratio	0.03	0.03	0.03	0.03	0.03	0.03
Debt / EBITDA Ratio	0.16	0.16	0.31	0.36	0.20	0.19
Debt / FCF Ratio	0.15	0.15	5.38	0.53	0.37	0.31
Asset Turnover	0.52	0.52	0.43	0.44	0.46	0.47
Inventory Turnover	1.96	1.96	2.05	2.19	2.28	2.48
Quick Ratio	3.01	3.01	4.68	4.49	4.98	4.60
Current Ratio	3.67	3.67	5.62	5.27	5.81	5.34
Return on Equity (ROE)	9.41%	9.41%	5.72%	3.95%	6.96%	10.13%
Return on Assets (ROA)	7.26%	7.26%	3.52%	3.02%	6.49%	6.92%
Return on Capital (ROIC)	8.65%	8.65%	4.13%	3.54%	7.56%	8.16%
Return on Capital Employed (ROCE)	13.10%	13.10%	6.20%	5.50%	11.70%	12.50%
Earnings Yield	9.41%	7.89%	6.13%	3.93%	6.49%	8.07%
FCF Yield	17.31%	14.50%	0.55%	5.25%	7.03%	7.47%
Dividend Yield	4.87%	3.81%	4.14%	3.85%	3.10%	3.69%
Payout Ratio	51.62%	51.62%	70.49%	103.84%	59.84%	43.35%
Buyback Yield / Dilution	-1.13%	-1.13%	-0.44%	1.07%	1.59%	1.41%
Total Shareholder Return	3.75%	2.68%	3.70%	4.93%	4.69%	5.09%

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.